Original Article Adenovirus-Delivered PDCD5 Counteracts Adriamycin Resistance of Osteosarcoma Cells Through Enhancing Apoptosis and Inhibiting Pgp

Total Page:16

File Type:pdf, Size:1020Kb

Original Article Adenovirus-Delivered PDCD5 Counteracts Adriamycin Resistance of Osteosarcoma Cells Through Enhancing Apoptosis and Inhibiting Pgp Int J Clin Exp Med 2014;7(12):5429-5436 www.ijcem.com /ISSN:1940-5901/IJCEM0002682 Original Article Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp Hui Zhao1, Changliang Peng2, Guorui Ruan3, Junlin Zhou1, Yihan Li1, Yong Hai1 1Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China; 2Department of Orthopedics, Second Affiliated Hospital, Shandong University, Jinan, China; 3Peking University People’s Hospital and Institute of Hematology, Beijing, China Received September 21, 2014; Accepted November 25, 2014; Epub December 15, 2014; Published December 30, 2014 Abstract: In the present study, we investigated the roles of PDCD5 (programmed cell death 5) in multidrug re- sistance (MDR) of osteosarcoma cells and the possible lurking mechanisms. An adenovirus expression vector of PDCD5 was constructed and transfected into human adriamycin-resistant osteosarcoma cell line Saos-2/ADM. We found that up-regulation of PDCD5 could significantly enhance the sensitivity of Saos-2/ADM cells towards vincris- tine, methotrexate, cisplatin and arsenic trioxide (As2O3), and could decrease the capacity of cells to efflux adria- mycin. PDCD5 could significantly down regulate the expression of P-glycoprotein (Pgp), but not affect the expression of multidrug resistance associated protein (MRP) or the glutathione S-transferase (GST). PDCD5 was also able to significantly increase the apoptotic activity of modified osteosarcoma cells. Further study of the biological functions of PDCD5 might be helpful in the understanding of the mechanisms of multidrug resistance (MDR) in osteosarcoma and exploring PDCD5 based adjuvant genetic therapy. Keywords: Osteosarcoma, MDR, PDCD5, apoptosis Introduction drug-induced apoptosis, up-regulation of lipids and other biochemical changes [5-9]. However, Osteosarcoma is the most common primary the precise mechanisms of MDR have not been malignant bone tumor, mainly occurring in chil- fully elucidated to this day. dren and adolescents. Despite current treat- ment strategies, including a combination of PDCD5 (programmed cell death 5), earlier limb salvage surgery and neo-adjuvant chemo- named TF-1 apoptosis-related gene 19 (TFAR- therapy, long-term disease-free survival rates 19), is a novel apoptosis-related gene cloned as are between 60% and 76% in patients with an increased expression gene during the apop- localized disease. The patients whose tumors totic process of TF-1 cells induced by cytokine respond poorly to chemotherapy are at a higher withdrawal using a cDNA-RDA method. The risk of relapse and adverse outcome [1, 2]. The human PDCD5 gene encodes a protein ex- most challenging problem that orthopedics pressed in tumor cells, which is translocated oncologists must deal with is multidrug resis- rapidly from the cytoplasm into the nuclei of tance (MDR) induced by the classic chemother- cells during apoptosis. The appearance of apeutic agents, such as vincristine, methotrex- PDCD5 in the nuclei of apoptotic cells precedes ate, adriamycin and cisplatin [1-4]. Previous the externalization of phosphatidylserine and reports revealed a diverse range of possible fragmentation of chromosomal DNA. And the mechanisms of MDR, such as extrusion of drug nuclear translocation of PDCD5 is a universal by cell membrane pumps, increase of drug early event of the apoptotic process, and may detoxification, DNA damage repair, redistribu- be a novel early marker for apoptosis [10]. tion of intracellular drug accumulation, modifi- Several pieces of evidence have suggested that cation of drug target molecules, suppression of the expression of PDCD5 protein is down-regu- Adenovirus-delivered PDCD5 enhances apoptosis and inhibiting Pgp lated in some human tumors, such as breast manufacturer’s instructions. Reverse transcrip- cancer [11], hepatocellular carcinoma [12] and tion was performed and cDNAs were amplified gastric cancer [13]. with the following primer pairs. PDCD5, for- ward: 5’-GTGATGCGGCCCAACAG-3’; reverse: In the previous study, we have firstly found that 5’-ATCCAGAACTTGGGCTAAGATACTG-3’; and be- PDCD5 would facilitate the sensitivity of K562 ta-actin, forward: 5’-AGCGGGAAATCGTGCGT- cells to idarubicin in vitro and in vivo, suggest- G-3’; reverse: 5’-CAGGGTACATGGTGGTGCC-3’. ing that the PDCD5 might transfer high sensitiv- All of the PCR products were analyzed on 2.0% ity to other anticancer drugs through apoptosis agarose gels [16]. [14]. Here the potential roles of PDCD5 in Adriamycin resistant osteosarcoma cell line Western blotting and the possible underlying mechanisms were further investigated. The results showed that Cells were plated at 5 × 105 per well in six well PDCD5 might mediate Adriamycin resistance of plates. The following day, cells were treated osteosarcoma through regulation of Pgp and with different anticancer drugs. After treat- apoptosis. ment, for whole-cell extracts, cells were washed with PBS and lysed in the culture dishes using Methods and materials lysis buffer (150 mM NaCl, 50 mM Tris-HCL, pH Cell lines and culture 7.4, 2 mM EDTA, 1% NP-40) containing prote- ase inhibitors. Then the total cellular proteins The human osteosarcoma cell line Saos-2, was were quantified by Bradford method. Equal obtained from Memorial Sloan-Kettering Can- amounts of total protein (50-100 μg per lane) cer Center. Human Adriamycin-resistant osteo- were electrophoresed in 12% SDS-PAGE and sarcoma cell line Saos-2/ADM was selected in blotted on a nitrocellulose membrane (0.45 vitro by growing them in progressively increas- μm, Millipore, USA) in 25 mM Tris-base, 190 ing drug concentrations in the medium as mM glycine, and 20% methanol using a semi- described previously [15]. All the cells were rou- dry blotter. Membranes were blocked with 8% tinely maintained in high-glucose Dulbecco’s fat-free milk powder at room temperature for 2 Modified Eagle’s Minimum Essential Medium hours and incubated overnight with primary (DMEM) (Invitrogen Co., Carlsbad, CA) supple- antibody at 4°C. After three washes for 15 min- mented with 10% heat-inactivated fetal calf utes in PBS-Tween 20, the membrane was incu- serum (Gibco) in 37°C humidified incubator bated with the horseradish peroxidase-conju- with a mixture of 95% air and 5% CO2, fed every gated goat anti-mouse IgG antibody for 1 hour 3 days with complete medium, and subcultrued at room temperature. The membrane was when confluence was reached. washed again in PBS-Tween 20; enhanced che- miluminescence (Amersham, NJ) was added Adenovirus infection and monitored for the development of color. The construction and purification of Ad-null and The following antibodies were used: anti-Pgp, Ad-PDCD5 (E1, E3 deleted, CMV promoter) anti-MRP, anti-GST, anti-Bcl-2, anti-cleaved were performed by the AGTC Gene Technology caspase-3, anti-PDCD5, and anti-beta-actin. All Company Ltd. (Beijing, China). For infections, these antibodies were from Santa Cruz Bio- cells were plated in DMEM supplemented with technology (Santa Cruz, CA). The density of the 10% heat-inactivated fetal calf serum and cul- bands was assessed using the BioRad Mul- tured until they achieved 70-80% confluence. tianalyst software (BioRad, Hercules, CA). Culture medium was then replaced with low- In vitro drug sensitivity assay serum media (containing 0.5% FBS), and then infected 24 h later with 400 multiplicities of Different anticancer drugs were freshly pre- infection (MOI). After 36 h, cells were washed pared before each experiment. Drug sensitivity with PBS, and fresh standard medium was was assessed using 3-(4,5-dimethylthiazol- added for subsequently study. 2-yl)-2,5-diphenyltetrazolium bromide (MTT) RT-PCR assay [17]. Briefly, cells were diluted with the standard culture medium to the seeding densi- Total RNA was extracted from cells using TRIzol ty (1 × 104/well), suspended in 96-well plates reagent (Invitrogen, Carlsbad, CA), following the (200 μl/well), and incubated at 37°C for 24 5430 Int J Clin Exp Med 2014;7(12):5429-5436 Adenovirus-delivered PDCD5 enhances apoptosis and inhibiting Pgp hours. Then, cells were incubated for 72 hours tion in a water bath at 37°C for 30 minutes, the in the absence or presence of various concen- DNA samples were analyzed on 2.0% agarose trations of the anticancer agents in 200 μl gel containing 0.1 μg/ml ethidium bromide. medium. Each assay was performed according to the manufacturer’s instructions. All samples Annexin V staining and standards were run in triplicate. After cells being cultured for 72 hours, 50 μl of 2 mg/ml After incubation with 2 μg/ml of Adriamycin, MTT (Sigma) was added into each well, and Adriamycin resistant cells were washed twice cells were cultured for another 4 hours. Then, with cold PBS and resuspended in 100 μl bind- 6 supernatants were discarded and 150 μl DMSO ing buffer at a concentration of 1 × 10 /ml. (Sigma) was added into each well to dissolve Then, 5 μl Annexin V-FITC (BD Biosciences, crystals. Absorbance was determined by spec- USA) and 10 μl of 20 μg/ml propidium iodide trophotometry (Biohit, BP800, Finland) using a (50 μg/mL, Sigma) were added to these cells. wavelength of 490 nm. Cell survival rates were After incubation at room temperature for 15 calculated according to the formula: survival minutes, 400 μl Annexin-binding buffer was rate = (mean A490 of treated wells/mean A490 added to each sample, and the samples were of untreated wells) × 100%. Finally, the IC50s kept on ice for counting the stained cells by flow of different
Recommended publications
  • Nuclear Translocation of PDCD5 (TFAR19): Provided by Elsevier - Publisher Connector an Early Signal for Apoptosis?
    FEBS 25453 FEBS Letters 509 (2001) 191^196 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Nuclear translocation of PDCD5 (TFAR19): provided by Elsevier - Publisher Connector an early signal for apoptosis? Yingyu Chen, Ronghua Sun, Wenling Han, Yingmei Zhang, Quansheng Song, Chunhui Di, Dalong Ma* Laboratory of Medical Immunology, School of Basic Medical Science, Peking University, 38 Xueyuan Road, Beijing 100083, PR China Received 20 July 2001; revised 14 September 2001; accepted 16 October 2001 First published online 7 November 2001 Edited by Vladimir Skulachev could accelerate apoptosis of some tumor cells (HeLa, TF-1, Abstract The programmed cell death 5 (PDCD5) protein is a novel protein related to regulation of cell apoptosis. In this HL60, MCG-803, MCF-7) [5,7]. In order to further study the report, we demonstrate that the level of PDCD5 protein biological activities of PDCD5, we successfully produced spe- expressed in cells undergoing apoptosis is significantly increased ci¢c monoclonal antibodies against PDCD5. Then, we used compared with normal cells, then the protein translocates rapidly these monoclonal antibodies as probes to observe the expres- from the cytoplasm to the nucleus of cells. The appearance of sion and localization of PDCD5 in cell apoptosis process. We PDCD5 in the nuclei of apoptotic cells precedes the externaliza- demonstrate that PDCD5 protein can translocate to the nu- tion of phosphatidylserine and fragmentation of chromosome cleus rapidly in cells undergoing apoptosis and the accumu- DNA. This phenomenon is parallel to the loss of mitochondrial lation of PDCD5 in the nucleus precedes the chromosome membrane potential, independent of the feature of apoptosis- DNA fragmentation and phosphatidylserine (PS) externaliza- inducing stimuli and also independent of the cell types and the tion.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Structure–Function Correlation of Human Programmed Cell Death 5 Protein
    Archives of Biochemistry and Biophysics 486 (2009) 141–149 Contents lists available at ScienceDirect Archives of Biochemistry and Biophysics journal homepage: www.elsevier.com/locate/yabbi Structure–function correlation of human programmed cell death 5 protein Hongwei Yao a,1, Lanjun Xu b,1, Yingang Feng a, Dongsheng Liu a, Yingyu Chen b,*, Jinfeng Wang a,* a National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China b Laboratory of Medical Immunology, School of Basic Medical Science, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083, China article info abstract Article history: Human programmed cell death 5 (PDCD5) is a translocatory protein playing an important role in the Received 4 March 2009 apoptotic process of cells. Although there are accumulated data about PDCD5 function, the correlation and in revised form 25 March 2009 of the structure with the function of PDCD5 has not been investigated. Here, we report the studies of Available online 7 April 2009 structure–function relationship of PDCD5 by multidimensional NMR methods and by FACScan flow cytometer and fluorescence microscope. The 3D structure of intact PDCD5 and the internal motions of Keywords: PDCD5 have been determined. PDCD5 has a compact core structure of low flexibility with two mobile PDCD5 a-helices at N-terminal region and a flexible unstructured C-terminal region. The flow cytometry and NMR internalization measurements of different PDCD5 fragments indicate that the charged residues are crucial Structure–function relationship Cell translocation for the ability of apoptosis-promoting and cell translocation of the protein. Combined analyses reveal a Fragments of PDCD5 fact that the regions that seem to be most involved in the function also are more flexible in PDCD5.
    [Show full text]
  • The 5V-Upstream Region of Human Programmed Cell Death 5 Gene Contains a Highly Active TATA-Less Promoter That Is Up-Regulated by Etoposide
    http://www.paper.edu.cn Gene 329 (2004) 39–49 www.elsevier.com/locate/gene The 5V-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide Mingxu Xu*, Ning Cheng, Liming Gui, Mouyi Lai, Ying Wang, Donglan Xia, Min Rui, Yingmei Zhang, Dalong Ma Laboratory of Medical Immunology, School of Basic Medical Sciences, Peking University Center for Human Disease Genomics, 38 Xueyuan Road, Beijing 100083, China Received 9 June 2003; received in revised form 3 December 2003; accepted 23 December 2003 Received by R. Di Lauro Abstract The PDCD5 (programmed cell death 5), a novel apoptosis related gene, is functionally associated with cell apoptosis, exhibits a ubiquitous expression pattern and is up-regulated in some types of tumor cells undergoing apoptosis. To study the transcriptional regulation of the PDCD5 gene, we have cloned 1.1 kb of its 5V-upstream region. The DNA sequencing analysis revealed a major transcriptional start site at 72 base pairs in front of the ATG translational start codon. The upstream of the transcriptional start site lacks a canonical TATA box and CAAT box. Transient transfection and luciferase assay demonstrate that this region presents extremely strong promoter activity. The 5V- deleted sequences fused to a luciferase reporter gene demonstrated that the À 555/ À 383 region from the transcription start site is crucial for transcriptional regulation, and the luciferase reporter gene’s expression significantly increased in the early stage of cell apoptosis induced by etoposide. These results imply that the PDCD5 gene may be a target gene under the control of some important apoptosis-related transcriptional factors during the cell apoptosis.
    [Show full text]
  • Bioinformatics Analysis for the Identification of Differentially Expressed Genes and Related Signaling Pathways in H
    Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells Dingyu Chen*, Chao Li, Yan Zhao, Jianjiang Zhou, Qinrong Wang and Yuan Xie* Key Laboratory of Endemic and Ethnic Diseases , Ministry of Education, Guizhou Medical University, Guiyang, China * These authors contributed equally to this work. ABSTRACT Aim. Helicobacter pylori cytotoxin-associated protein A (CagA) is an important vir- ulence factor known to induce gastric cancer development. However, the cause and the underlying molecular events of CagA induction remain unclear. Here, we applied integrated bioinformatics to identify the key genes involved in the process of CagA- induced gastric epithelial cell inflammation and can ceration to comprehend the potential molecular mechanisms involved. Materials and Methods. AGS cells were transected with pcDNA3.1 and pcDNA3.1::CagA for 24 h. The transfected cells were subjected to transcriptome sequencing to obtain the expressed genes. Differentially expressed genes (DEG) with adjusted P value < 0.05, | logFC |> 2 were screened, and the R package was applied for gene ontology (GO) enrichment and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. The differential gene protein–protein interaction (PPI) network was constructed using the STRING Cytoscape application, which conducted visual analysis to create the key function networks and identify the key genes. Next, the Submitted 20 August 2020 Kaplan–Meier plotter survival analysis tool was employed to analyze the survival of the Accepted 11 March 2021 key genes derived from the PPI network. Further analysis of the key gene expressions Published 15 April 2021 in gastric cancer and normal tissues were performed based on The Cancer Genome Corresponding author Atlas (TCGA) database and RT-qPCR verification.
    [Show full text]
  • Miz1 Is Required to Maintain Autophagic Flux
    ARTICLE Received 3 Apr 2013 | Accepted 3 Sep 2013 | Published 3 Oct 2013 DOI: 10.1038/ncomms3535 Miz1 is required to maintain autophagic flux Elmar Wolf1,*, Anneli Gebhardt1,*, Daisuke Kawauchi2, Susanne Walz1, Bjo¨rn von Eyss1, Nicole Wagner3, Christoph Renninger3, Georg Krohne1, Esther Asan3, Martine F. Roussel2 & Martin Eilers1,4 Miz1 is a zinc finger protein that regulates the expression of cell cycle inhibitors as part of a complex with Myc. Cell cycle-independent functions of Miz1 are poorly understood. Here we use a Nestin-Cre transgene to delete an essential domain of Miz1 in the central nervous system (Miz1DPOZNes). Miz1DPOZNes mice display cerebellar neurodegeneration characterized by the progressive loss of Purkinje cells. Chromatin immunoprecipitation sequencing and biochemical analyses show that Miz1 activates transcription upon binding to a non-palin- dromic sequence present in core promoters. Target genes of Miz1 encode regulators of autophagy and proteins involved in vesicular transport that are required for autophagy. Miz1DPOZ neuronal progenitors and fibroblasts show reduced autophagic flux. Consistently, polyubiquitinated proteins and p62/Sqtm1 accumulate in the cerebella of Miz1DPOZNes mice, characteristic features of defective autophagy. Our data suggest that Miz1 may link cell growth and ribosome biogenesis to the transcriptional regulation of vesicular transport and autophagy. 1 Theodor Boveri Institute, Biocenter, University of Wu¨rzburg, Am Hubland, 97074 Wu¨rzburg, Germany. 2 Department of Tumor Cell Biology, MS#350, Danny Thomas Research Center, 5006C, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA. 3 Institute for Anatomy and Cell Biology, University of Wu¨rzburg, Koellikerstrasse 6, 97070 Wu¨rzburg, Germany. 4 Comprehensive Cancer Center Mainfranken, Josef-Schneider-Strasse 6, 97080 Wu¨rzburg, Germany.
    [Show full text]
  • Chromatin Conformation Links Distal Target Genes to CKD Loci
    BASIC RESEARCH www.jasn.org Chromatin Conformation Links Distal Target Genes to CKD Loci Maarten M. Brandt,1 Claartje A. Meddens,2,3 Laura Louzao-Martinez,4 Noortje A.M. van den Dungen,5,6 Nico R. Lansu,2,3,6 Edward E.S. Nieuwenhuis,2 Dirk J. Duncker,1 Marianne C. Verhaar,4 Jaap A. Joles,4 Michal Mokry,2,3,6 and Caroline Cheng1,4 1Experimental Cardiology, Department of Cardiology, Thoraxcenter Erasmus University Medical Center, Rotterdam, The Netherlands; and 2Department of Pediatrics, Wilhelmina Children’s Hospital, 3Regenerative Medicine Center Utrecht, Department of Pediatrics, 4Department of Nephrology and Hypertension, Division of Internal Medicine and Dermatology, 5Department of Cardiology, Division Heart and Lungs, and 6Epigenomics Facility, Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands ABSTRACT Genome-wide association studies (GWASs) have identified many genetic risk factors for CKD. However, linking common variants to genes that are causal for CKD etiology remains challenging. By adapting self-transcribing active regulatory region sequencing, we evaluated the effect of genetic variation on DNA regulatory elements (DREs). Variants in linkage with the CKD-associated single-nucleotide polymorphism rs11959928 were shown to affect DRE function, illustrating that genes regulated by DREs colocalizing with CKD-associated variation can be dysregulated and therefore, considered as CKD candidate genes. To identify target genes of these DREs, we used circular chro- mosome conformation capture (4C) sequencing on glomerular endothelial cells and renal tubular epithelial cells. Our 4C analyses revealed interactions of CKD-associated susceptibility regions with the transcriptional start sites of 304 target genes. Overlap with multiple databases confirmed that many of these target genes are involved in kidney homeostasis.
    [Show full text]
  • Research Article
    Breast Cancer Research Vol 6 No 2 Clarkson et al. Research article Open Access Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression Richard WE Clarkson1, Matthew T Wayland2, Jennifer Lee2, Tom Freeman2 and Christine J Watson1 1Department of Pathology, University of Cambridge, Cambridge, UK 2MRC-HGMP Resource Centre, Hinxton, UK Correspondence: Richard WE Clarkson (e-mail: [email protected]) Received: 22 Sep 2003 Revisions requested: 12 Nov 2003 Revisions received: 15 Nov 2003 Accepted: 21 Nov 2003 Published: 18 Dec 2003 Breast Cancer Res 2004, 6:R92-R109 (DOI 10.1186/bcr754) © 2004 Clarkson et al., licensee BioMed Central Ltd (Print ISSN 1465-5411; Online ISSN 1465-542X). This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. See related Research article: http://breast-cancer-research.com/content/6/2/R75 and related Commentary: http://breast-cancer-research.com/content/6/2/89 Abstract Introduction In order to gain a better understanding of the transducer and activator of signalling-3) signalling. Before molecular processes that underlie apoptosis and tissue involution, expected increases in cell proliferation, biosynthesis regression in mammary gland, we undertook a large-scale and metabolism-related genes were observed. During analysis of transcriptional changes during the mouse mammary involution, the first 24 hours after weaning was characterized pregnancy cycle, with emphasis on the transition from lactation by a transient increase in expression of components of the to involution.
    [Show full text]
  • Focused Examination of the Intestinal Lamina Propria Yields Greater Molecular Insight Into Mechanisms Underlying SIV Induced Immune Dysfunction
    Focused Examination of the Intestinal lamina Propria Yields Greater Molecular Insight into Mechanisms Underlying SIV Induced Immune Dysfunction Mahesh Mohan1, Deepak Kaushal2, Pyone P. Aye1, Xavier Alvarez1, Ronald S. Veazey1, Andrew A. Lackner1* 1 Division of Comparative Pathology, Tulane National Primate Research Center, Covington, Louisiana, United States of America, 2 Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, Louisiana, United States of America Abstract Background: The Gastrointestinal (GI) tract is critical to AIDS pathogenesis as it is the primary site for viral transmission and a major site of viral replication and CD4+ T cell destruction. Consequently GI disease, a major complication of HIV/SIV infection can facilitate translocation of lumenal bacterial products causing localized/systemic immune activation leading to AIDS progression. Methodology/Principal Findings: To better understand the molecular mechanisms underlying GI disease we analyzed global gene expression profiles sequentially in the intestine of the same animals prior to and at 21 and 90d post SIV infection (PI). More importantly we maximized information gathering by examining distinct mucosal components (intraepithelial lymphocytes, lamina propria leukocytes [LPL], epithelium and fibrovascular stroma) separately. The use of sequential intestinal resections combined with focused examination of distinct mucosal compartments represents novel approaches not previously attempted. Here we report data pertaining to the LPL. A significant increase (61.7-fold) in immune defense/inflammation, cell adhesion/migration, cell signaling, transcription and cell division/differentiation genes were observed at 21 and 90d PI. Genes associated with the JAK-STAT pathway (IL21, IL12R, STAT5A, IL10, SOCS1) and T-cell activation (NFATc1, CDK6, Gelsolin, Moesin) were notably upregulated at 21d PI.
    [Show full text]
  • Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy
    Research Article Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy Tsz-Kwong Man,1 Murali Chintagumpala,1 Jaya Visvanathan,1 Jianhe Shen,1 Laszlo Perlaky,1 John Hicks,2 Mark Johnson,3 Nelson Davino,3 Jeffrey Murray,4 Lee Helman,5 William Meyer,6 Timothy Triche,7 Kwong-Kwok Wong,1 and Ching C. Lau1 1Departments of Pediatrics, Texas Children’s Cancer Center; Departments of 2Pathology and 3Orthopedic Surgery, Texas Children’s Hospital/Baylor College of Medicine, Houston, Texas; 4Cook Children’s Medical Center, Fort Worth, Texas; 5Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland; 6University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; and 7Children’s Hospital Los Angeles, Los Angeles, California Abstract the resected tumor specimen is assessed for the degree of necrosis, Osteosarcoma is the most common malignant bone tumor in which is a reliable and the only significant prognostic factor in children. After initial diagnosis is made with a biopsy, patients with nonmetastatic disease and is used to guide the choice treatment consists of preoperative chemotherapy followed by of postoperative chemotherapy. Patients whose tumors display z definitive surgery and postoperative chemotherapy. The 90% necrosis (good or favorable response) have an excellent degree of tumor necrosis in response to preoperative prognosis and continue to receive chemotherapy similar to the chemotherapy is a reliable prognostic factor and is used to preoperative regimen. Patients whose tumors display <90% guide the choice of postoperative chemotherapy. Patients necrosis (poor or unfavorable response) have a much higher risk with tumors, which reveal z90% necrosis (good responders), of relapse and poor outcome even after complete resection of the have a much better prognosis than those with <90% necrosis primary tumor (2).
    [Show full text]
  • A Genomic View of Estrogen Actions in Human Breast Cancer Cells by Expression Profiling of the Hormone-Responsive Transcriptome
    719 A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome Luigi Cicatiello1, Claudio Scafoglio1, Lucia Altucci1, Massimo Cancemi1, Guido Natoli1, Angelo Facchiano2, Giovanni Iazzetti3, Raffaele Calogero4, Nicoletta Biglia6, Michele De Bortoli5,7, Christian Sfiligoi7, Piero Sismondi6,7, Francesco Bresciani1 and Alessandro Weisz1 1Dipartimento di Patologia generale, Seconda Università degli Studi di Napoli, Vico L. De Crecchio 7, 80138 Napoli, Italy 2Istituto di Scienze dell’Alimentazione del Consiglio Nazionale delle Ricerche, Avellino, Italy 3Dipartimento di Genetica, Biologia generale e molecolare, Università di Napoli ‘Federico II’, Napoli, Italy 4Dipartimento di Scienze cliniche e biologiche, Università degli Studi di Torino, Torino, Italy 5Dipartimento di Scienze oncologiche, Università degli Studi di Torino, Torino, Italy 6Dipartimento di Discipline ostetriche e ginecologiche, Università degli Studi di Torino, Torino, Italy 7Laboratorio di Ginecologia oncologica, Istituto per la Ricerca e la Cura del Cancro, Candiolo, Italy (Requests for offprints should be addressed to A Weisz; Email: [email protected]) Abstract Estrogen controls key cellular functions of responsive cells including the ability to survive, replicate, communicate and adapt to the extracellular milieu. Changes in the expression of 8400 genes were monitored here by cDNA microarray analysis during the first 32 h of human breast cancer (BC) ZR-75·1 cell stimulation with a mitogenic dose of 17-estradiol, a timing which corresponds to completion of a full mitotic cycle in hormone-stimulated cells. Hierarchical clustering of 344 genes whose expression either increases or decreases significantly in response to estrogen reveals that the gene expression program activated by the hormone in these cells shows 8 main patterns of gene activation/inhibition.
    [Show full text]
  • Identification of Novel Regulatory Genes in Acetaminophen
    IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN A THESIS IN Cell Biology and Biophysics and Bioinformatics Presented to the Faculty of the University of Missouri-Kansas City in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY By KATHERINE ANNE SHORTT B.S, Indiana University, Bloomington, 2011 M.S, University of Missouri, Kansas City, 2014 Kansas City, Missouri 2018 © 2018 Katherine Shortt All Rights Reserved IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN Katherine Anne Shortt, Candidate for the Doctor of Philosophy degree, University of Missouri-Kansas City, 2018 ABSTRACT Acetaminophen (APAP) is a commonly used analgesic responsible for over 56,000 overdose-related emergency room visits annually. A long asymptomatic period and limited treatment options result in a high rate of liver failure, generally resulting in either organ transplant or mortality. The underlying molecular mechanisms of injury are not well understood and effective therapy is limited. Identification of previously unknown genetic risk factors would provide new mechanistic insights and new therapeutic targets for APAP induced hepatocyte toxicity or liver injury. This study used a genome-wide CRISPR/Cas9 screen to evaluate genes that are protective against or cause susceptibility to APAP-induced liver injury. HuH7 human hepatocellular carcinoma cells containing CRISPR/Cas9 gene knockouts were treated with 15mM APAP for 30 minutes to 4 days. A gene expression profile was developed based on the 1) top screening hits, 2) overlap with gene expression data of APAP overdosed human patients, and 3) biological interpretation including assessment of known and suspected iii APAP-associated genes and their therapeutic potential, predicted affected biological pathways, and functionally validated candidate genes.
    [Show full text]